- Awards
- 15
- Value outside frameworks
- Framework places and shared awards only
- Framework places
- 13
- Shared awards
- 2
Values exclude VAT where the notices give it, and only values in pounds are added up. A framework place carries the framework's whole ceiling, shared with the other suppliers on it, so framework places are counted rather than added up; so are awards made to several suppliers together. Every award here is a framework place or shared.
Awards
| Procurement | Buyer | Value | Date |
| NHS National Generic Pharmaceuticals - Wave 16a Lot 1 framework |
NHS England |
£15,529,352 |
27 Aug 2026 |
| NHS National Generic Pharmaceuticals - Wave 16a Lot 2 framework |
NHS England |
£393,331,872 |
27 Aug 2026 |
| NHS National Generic Pharmaceuticals - Wave 16a Lot 3 framework |
NHS England |
£21,026,178 |
27 Aug 2026 |
| NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026 Lot 1 framework |
NHS England |
£665,389,588 |
6 Jul 2026 |
| NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 Lot 2 framework |
NHS England |
£18,903,212 |
6 Jul 2026 |
| NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026 Lot 1 framework |
NHS England |
£665,389,588 |
15 Jun 2026 |
| NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026 Lot 2 framework |
NHS England |
£35,312,548 |
15 Jun 2026 |
| Ustekinumab shared |
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) |
£6,532,463 |
4 Jun 2026 |
| NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 Lot 1 framework |
NHS England |
£813,863,584 |
1 Jun 2026 |
| NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 Lot 2 framework |
NHS England |
£18,903,212 |
1 Jun 2026 |
| Transitional Drugs 6 shared |
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) |
£1,637,726 |
29 Jan 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c Lot 2 framework |
NHS England |
£403,702,000 |
13 Jan 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c Lot 3 framework |
NHS England |
£37,160,000 |
13 Jan 2026 |
| NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 Lot 1 framework |
NHS England |
£782,917,972 |
22 Sep 2025 |
| NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 Lot 1 framework |
NHS England |
£688,834,174 |
31 Jul 2025 |
Top buyers
By number of awards. Value is the total of awards made to this supplier alone outside frameworks, excluding VAT where the notices give it.